Race As a Predictor of Recurrence and Complications After Urethroplasty in Men With Urethral Stricture Disease

Overview

Journal Urology

Specialty Urology

Date 2021 Dec 1

PMID 34852248

Citations 1

Authors

Kathryn N Sawyer

Stacey S Cofield

John P Selph

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the role of race in surgical outcomes of and complications after urethroplasty.

Methods: A single institution, retrospective review was conducted from 2011 to 2019 on male patients ≥18 years of age who underwent urethroplasty. Exclusion criteria included previous urethral cancer, lack of follow up, or revision urethroplasty. Failure of urethroplasty was defined as requiring revision surgery or recurrence on imaging or cystoscopy. Risk factors for recurrence were determined using descriptive statistics, Wilcoxon comparisons, and multivariate logistic regression.

Results: Three hundred and seven patients were identified with 234 patients meeting inclusion criteria. 63.2% identified as White/Caucasian (CA), 32.5% Black/African American (AA), and 4.3% other race. Mean age was 49.4 years. Between CA and AA patients, there was no difference in mean age, body mass index, smoking status, prior urethroplasty, or prior dilation/DVIU. CAs were more likely to have a fossa navicularis stricture compared to AAs (P = .0094), but there were no significant differences in bulbar, penile, or posterior stricture rates (all P >.05) or length (P = .32). The overall stricture recurrence rate was 15.8% with a median of 242 days to recurrence and no significant difference by race for either outcome (P = .83, P = .64). The only predictor of stricture recurrence was prior dilation/DVIU (P = .0404, OR 2.3, 95% CI 1.0, 5.6). Overall complication rate was 17.5%, with no difference between CA and AAs rates (P = .83) or complication type (P = .62).

Conclusion: There was no significant difference in the rate of surgical failure for urethral stricture repair based on race. The only predictor of surgical failure was having a prior urethral dilation/DVIU.

Citing Articles

Impact of race and ethnicity on clinical outcomes and recurrence post-ureteral reconstruction.

Puri D, Cho E, Ahmadieh K, Garg N, Delgado C, Cedars B BJUI Compass. 2025; 5(12):1255-1262.

PMID: 39744078 PMC: 11685172. DOI: 10.1002/bco2.450.

References

Anger J, Buckley J, Santucci R, Elliott S, Saigal C . Trends in stricture management among male Medicare beneficiaries: underuse of urethroplasty?. Urology. 2010; 77(2):481-5. PMC: 3320109. DOI: 10.1016/j.urology.2010.05.055. View

Chapman D, Kinnaird A, Rourke K . Independent Predictors of Stricture Recurrence Following Urethroplasty for Isolated Bulbar Urethral Strictures. J Urol. 2017; 198(5):1107-1112. DOI: 10.1016/j.juro.2017.05.006. View

Keith C, Davenport M, Kavoussi M, Yi Y, Bergeson R, Morey A . Long-term outcomes of anastomotic urethroplasty for radiation-induced strictures. World J Urol. 2019; 38(12):3055-3060. DOI: 10.1007/s00345-019-03028-7. View

Meyer P, Penman-Aguilar A, Campbell V, Graffunder C, OConnor A, Yoon P . Conclusion and future directions: CDC Health Disparities and Inequalities Report - United States, 2013. MMWR Suppl. 2013; 62(3):184-6. View

Stone B, Laviana A, Luckenbaugh A, Huang L, Zhao Z, Koyama T . Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer. J Urol. 2020; 205(3):761-768. DOI: 10.1097/JU.0000000000001423. View

Wessells H, Angermeier K, Elliott S, Gonzalez C, Kodama R, Peterson A . Male Urethral Stricture: American Urological Association Guideline. J Urol. 2016; 197(1):182-190. DOI: 10.1016/j.juro.2016.07.087. View

Kaye D, Canner J, Kates M, Schoenberg M, Bivalacqua T . Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference. Bladder Cancer. 2016; 2(2):225-234. PMC: 4927827. DOI: 10.3233/BLC-150041. View

Wenzel M, Deuker M, Stolzenbach F, Nocera L, Colla Ruvolo C, Tian Z . The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer. Urol Oncol. 2020; 39(6):369.e9-369.e17. DOI: 10.1016/j.urolonc.2020.11.031. View

Richardson L, Norris M . Access to health and health care: how race and ethnicity matter. Mt Sinai J Med. 2010; 77(2):166-77. DOI: 10.1002/msj.20174. View

10.

Anger J, Santucci R, Grossberg A, Saigal C . The morbidity of urethral stricture disease among male medicare beneficiaries. BMC Urol. 2010; 10:3. PMC: 2837655. DOI: 10.1186/1471-2490-10-3. View

11.

Verla W, Oosterlinck W, Spinoit A, Waterloos M . A Comprehensive Review Emphasizing Anatomy, Etiology, Diagnosis, and Treatment of Male Urethral Stricture Disease. Biomed Res Int. 2019; 2019:9046430. PMC: 6500724. DOI: 10.1155/2019/9046430. View

12.

Breyer B, McAninch J, Whitson J, Eisenberg M, Mehdizadeh J, Myers J . Multivariate analysis of risk factors for long-term urethroplasty outcome. J Urol. 2009; 183(2):613-7. DOI: 10.1016/j.juro.2009.10.018. View

13.

Heyns C, Steenkamp J, De Kock M, Whitaker P . Treatment of male urethral strictures: is repeated dilation or internal urethrotomy useful?. J Urol. 1998; 160(2):356-8. DOI: 10.1016/s0022-5347(01)62894-5. View

14.

Barbagli G, Palminteri E, Lazzeri M, Guazzoni G, Turini D . Long-term outcome of urethroplasty after failed urethrotomy versus primary repair. J Urol. 2001; 165(6 Pt 1):1918-9. DOI: 10.1097/00005392-200106000-00018. View

15.

Davenport M, Wooliscroft J, McKibben M, Shakir N, Fuchs J, Yi Y . Age ≤40 is an independent predictor of anastomotic urethroplasty and successful repair of bulbar urethral strictures. Transl Androl Urol. 2020; 9(1):10-15. PMC: 6995941. DOI: 10.21037/tau.2019.08.34. View

16.

Baradaran N, Fergus K, Moses R, Patel D, Gaither T, Voelzke B . Clinical significance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi-institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS). World J Urol. 2019; 37(12):2763-2768. DOI: 10.1007/s00345-019-02653-6. View

17.

Fletcher S, Marchese M, Cole A, Mahal B, Friedlander D, Krimphove M . Geographic Distribution of Racial Differences in Prostate Cancer Mortality. JAMA Netw Open. 2020; 3(3):e201839. PMC: 7109596. DOI: 10.1001/jamanetworkopen.2020.1839. View

18.

Kinnaird A, Levine M, Ambati D, Zorn J, Rourke K . Stricture length and etiology as preoperative independent predictors of recurrence after urethroplasty: A multivariate analysis of 604 urethroplasties. Can Urol Assoc J. 2014; 8(5-6):E296-300. PMC: 4039590. DOI: 10.5489/cuaj.1661. View

19.

Oates G, Jackson B, Partridge E, Singh K, Fouad M, Bae S . Sociodemographic Patterns of Chronic Disease: How the Mid-South Region Compares to the Rest of the Country. Am J Prev Med. 2016; 52(1S1):S31-S39. PMC: 5171223. DOI: 10.1016/j.amepre.2016.09.004. View

20.

Washington D, Bowles J, Saha S, Horowitz C, Moody-Ayers S, Brown A . Transforming clinical practice to eliminate racial-ethnic disparities in healthcare. J Gen Intern Med. 2008; 23(5):685-91. PMC: 2324135. DOI: 10.1007/s11606-007-0481-0. View